OR WAIT null SECS
April 02, 2013
Industry is moving toward closed-loop control of continuous processing.
The European Union authorities are stepping up their efforts to incorporate quality-by-design principles into their regulations and guidelines.
March 02, 2013
The authors present topics discussed and conclusions that resulted from the PDA QbD workshop.
Companies risk drowning in alphabet soup if the latest three-letter acronym improvement strategy isn't clearly linked to business strategy.
Applying quality-by-design and process analytical technology facilitates process understanding and control of various operations in lyophilization.
QbD paradigm advances process understanding in development and manufacturing.
March 01, 2013
Factors for assessing excipient variability, the associated challenges developers need to address to design and manufacture solid oral drug products, and solutions for such challenges are examined.
The use of various documents and guides by the International Pharmaceutical Excipients Council can facilitate the flow of information among excipient manufacturers, distributors, and users.
December 02, 2012
Can postapproval FDA filings immunize pharma companies from patent lawsuits?
November 01, 2012
The author discusses current expectations in bioprocessing and lays a framework for using NMR to enhance a QbD approach.